239 related articles for article (PubMed ID: 19717090)
1. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials.
Powell JW; Dexter E; Scalzetti EM; Bogart JA
Lancet Oncol; 2009 Sep; 10(9):885-94. PubMed ID: 19717090
[TBL] [Abstract][Full Text] [Related]
2. Fractionated radiotherapy for high-risk patients with early-stage non-small cell lung cancer.
Bogart JA
Semin Thorac Cardiovasc Surg; 2010; 22(1):44-52. PubMed ID: 20813316
[TBL] [Abstract][Full Text] [Related]
3. Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.
Pennathur A; Abbas G; Christie N; Landreneau R; Luketich JD
Curr Opin Pulm Med; 2007 Jul; 13(4):267-70. PubMed ID: 17534171
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities.
Decker RH; Tanoue LT; Colasanto JM; Detterbeck FC; Wilson LD
Oncology (Williston Park); 2006 Jul; 20(8):899-905; discussion 905-8, 913. PubMed ID: 16922260
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.
Forquer JA; Fakiris AJ; McGarry RC; Cheung MK; Watson C; Harkenrider M; Henderson MA; Lo SS
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1443-53. PubMed ID: 19828006
[TBL] [Abstract][Full Text] [Related]
6. The treatment of early-stage disease.
Robinson CG; Bradley JD
Semin Radiat Oncol; 2010 Jul; 20(3):178-85. PubMed ID: 20685580
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
8. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer.
Widder J; Postmus D; Ubbels JF; Wiegman EM; Langendijk JA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e291-7. PubMed ID: 21640503
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy.
Decker RH; Tanoue LT; Colasanto JM; Detterbeck FC; Wilson LD
Oncology (Williston Park); 2006 Jun; 20(7):727-36. PubMed ID: 16841796
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
[TBL] [Abstract][Full Text] [Related]
11. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
Siedschlag C; Boersma L; van Loon J; Rossi M; van Baardwijk A; Gilhuijs K; Stroom J
Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665
[TBL] [Abstract][Full Text] [Related]
12. The contemporary role of radiation therapy in the management of lung cancer.
Mehta MP
Surg Oncol Clin N Am; 2000 Jul; 9(3):539-61, ix. PubMed ID: 10853141
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation: a safe and effective treatment in nonoperative patients with early-stage lung cancer.
Healey TT; Dupuy DE
Cancer J; 2011; 17(1):33-7. PubMed ID: 21263265
[TBL] [Abstract][Full Text] [Related]
14. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
[TBL] [Abstract][Full Text] [Related]
15. [Radiation therapy for lung cancer].
Hayakawa K; Nishiguchi I
Nihon Rinsho; 2002 May; 60 Suppl 5():404-7. PubMed ID: 12101700
[No Abstract] [Full Text] [Related]
16. Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer.
Odell DD; Kent MS; Fernando HC
Semin Thorac Cardiovasc Surg; 2010; 22(1):32-7. PubMed ID: 20813314
[TBL] [Abstract][Full Text] [Related]
17. [Stereotactic radiotherapy and radiofrequency ablation for early-stage lung cancer].
Piegay F; Girard N; Mornex JF
Bull Cancer; 2012 Nov; 99(11):1077-81. PubMed ID: 23113992
[TBL] [Abstract][Full Text] [Related]
18. Sublobar versus lobar resection: current status.
Narsule CK; Ebright MI; Fernando HC
Cancer J; 2011; 17(1):23-7. PubMed ID: 21263263
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
Iyengar P; Westover K; Timmerman RD
Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
